Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

Delve into the world of co-op survival games, where you and your friends will test your resource management, instincts, and ...

This is the first in a two-part series on Central America’s history and present, featuring scholars Hilary Goodfriend and ...

In its first full year on the U.S. market, bladder cancer treatment Adstiladrin earned about $77 million. Elsewhere, Lilly ...

Results of study directed by Rodrigo Toledo, Head of the Vall d'Hebron Institute of Oncology's (VHIO) Biomarkers and Clonal Dynamics Group, show convergent genetic adaptation under hypoxia (lack of ...